These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21310539)

  • 1. Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention.
    Magidson JF; Gorka SM; MacPherson L; Hopko DR; Blanco C; Lejuez CW; Daughters SB
    Addict Behav; 2011 Jun; 36(6):615-623. PubMed ID: 21310539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!).
    Daughters SB; Braun AR; Sargeant MN; Reynolds EK; Hopko DR; Blanco C; Lejuez CW
    J Clin Psychiatry; 2008 Jan; 69(1):122-9. PubMed ID: 18312046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a behavioral activation treatment for substance use on post-treatment abstinence: a randomized controlled trial.
    Daughters SB; Magidson JF; Anand D; Seitz-Brown CJ; Chen Y; Baker S
    Addiction; 2018 Mar; 113(3):535-544. PubMed ID: 28963853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial.
    Paquette CE; Reese ED; Yi JY; Maccarone JM; Stewart ZJ; Daughters SB
    Drug Alcohol Depend; 2023 Feb; 243():109758. PubMed ID: 36634574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating depression and substance use: a randomized controlled trial.
    Hunter SB; Watkins KE; Hepner KA; Paddock SM; Ewing BA; Osilla KC; Perry S
    J Subst Abuse Treat; 2012 Sep; 43(2):137-51. PubMed ID: 22301087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACT HEALTHY: A Combined Cognitive-Behavioral Depression and Medication Adherence Treatment for HIV-Infected Substance Users.
    Daughters SB; Magidson JF; Schuster RM; Safren SA
    Cogn Behav Pract; 2010 Aug; 17(3):309-321. PubMed ID: 21709737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial RCT of a distress tolerance treatment for individuals with substance use disorders.
    Bornovalova MA; Gratz KL; Daughters SB; Hunt ED; Lejuez CW
    Drug Alcohol Depend; 2012 Apr; 122(1-2):70-6. PubMed ID: 21983476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two depressive symptomatology measures in residential substance abuse treatment clients.
    Hepner KA; Hunter SB; Edelen MO; Zhou AJ; Watkins K
    J Subst Abuse Treat; 2009 Oct; 37(3):318-25. PubMed ID: 19359127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The moderating effects of group cognitive-behavioral therapy for depression among substance users.
    Hunter SB; Witkiewitz K; Watkins KE; Paddock SM; Hepner KA
    Psychol Addict Behav; 2012 Dec; 26(4):906-16. PubMed ID: 22564202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention.
    Ali B; Green KM; Daughters SB; Lejuez CW
    Addict Behav; 2017 Oct; 73():99-104. PubMed ID: 28500908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual diagnosis and successful participation of adolescents in substance abuse treatment.
    Wise BK; Cuffe SP; Fischer T
    J Subst Abuse Treat; 2001 Oct; 21(3):161-5. PubMed ID: 11728790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interacting effect of depressive symptoms, gender, and distress tolerance on substance use problems among residential treatment-seeking substance users.
    Ali B; Seitz-Brown CJ; Daughters SB
    Drug Alcohol Depend; 2015 Mar; 148():21-6. PubMed ID: 25578252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the retention rate for residential treatment of substance abuse by sequential intervention for social anxiety.
    Staiger PK; Kyrios M; Williams JS; Kambouropoulos N; Howard A; Gruenert S
    BMC Psychiatry; 2014 Feb; 14():43. PubMed ID: 24533512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of a combined cognitive behavior therapy and pharmacotherapy for a sample of women with and without substance abuse histories on an acute psychiatric unit: do therapeutic alliance and motivation matter?
    Clarke N; Mun EY; Kelly S; White HR; Lynch K
    Am J Addict; 2013; 22(6):566-73. PubMed ID: 24131164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of treatment resistance in depressed patients with substance use disorders.
    Nunes EV; Deliyannides D; Donovan S; McGrath PJ
    Psychiatr Clin North Am; 1996 Jun; 19(2):311-27. PubMed ID: 8827192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Web-Based Intervention to Reduce Substance Abuse and Depression: A Three Arm Randomized Trial in Mexico.
    Tiburcio M; Lara MA; Martínez N; Fernández M; Aguilar A
    Subst Use Misuse; 2018 Nov; 53(13):2220-2231. PubMed ID: 29768070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up.
    Nunes EV; Liu X; Samet S; Matseoane K; Hasin D
    J Clin Psychiatry; 2006 Oct; 67(10):1561-7. PubMed ID: 17107247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.